Optimising malignant melanoma management in Europe
EUMelaReg collects health information to improve care and treatment for patients with skin cancer
Sustaining and fostering collaboration between academia and industry
for the collection of baseline, treatment and outcome data of representative samples of malignant melanoma patients of major European countries.
Building the largest and quickest melanoma registry in the world
EUMelaReg collects real-world data on melanoma patients throughout Europe and integrates them in a data warehouse.

Sheba Tel-HaShomer Medical Centre joined EUMelaReg

We are pleased to announce that Sheba Tel-HaShomer Medical Center, specifically the Ella Lemelbaum Institute for Immun-Oncology and Melanoma (which is part of the Sheba Cancer Research Centre) has joined EUMelaReg. We are delighted to have a new enthusiastic partner from Israel on board, bringing our registry to 15 participating countries already.